Cognitive function testing in adult brain tumor trials: Lessons from a comprehensive review

Chip Caine, Minesh P. Mehta, Nadia N. Laack, Vinai Gondi

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Neurocognitive function (NCF) impairment is an important component of primary and metastatic brain tumors and their therapeutic interventions. As a result, modern clinical trials of cranial irradiation for adult cancer patients have incorporated NCF testing as a primary or secondary end point. In doing so, these clinical trials have provided a novel insight into our understanding of the NCF effects of cranial irradiation and brain tumor progression. In this article, we review these clinical trials both in terms of the trial findings and in terms of the types of NCF tests used in these trials. We also provide an introduction to the strengths and limitations of these NCF tests, as well as expert commentary on the current status and future directions of NCF testing in brain tumor trials.

Original languageEnglish (US)
Pages (from-to)655-667
Number of pages13
JournalExpert review of anticancer therapy
Issue number5
StatePublished - May 2012


  • Hopkins Verbal Learning Test
  • Mini-Mental Status Exam
  • Stroop test
  • Trail Making Tests
  • brain tumors
  • cranial irradiation
  • neurocognitive function
  • whole-brain radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Cognitive function testing in adult brain tumor trials: Lessons from a comprehensive review'. Together they form a unique fingerprint.

Cite this